Keywords: میلوفیفروس اولیه; Acute respiratory distress syndrome; Primary myelofibrosis; Ruxolitinib;
مقالات ISI ترجمه شده میلوفیفروس اولیه
مقالات ISI میلوفیفروس اولیه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: میلوفیفروس اولیه; Philadelphia chromosome negative myeloproliferative neoplasm; Primary myelofibrosis; Survival; Iron metabolism; Transferrin saturation; Functional iron deficiency;
Keywords: میلوفیفروس اولیه; AA; arachidonic acid; ADP; adenosine diphosphate; CALR; calreticulin; ET; essential thrombocythemia; HRPR; high on-treatment residual platelet reactivity; JAK; janus kinase; MEA; multiple electrode aggregometry; MPL; myeloproliferative leukemia virus onco
Keywords: میلوفیفروس اولیه; Myeloid sarcoma; Primary myelofibrosis; Calreticulin;
Keywords: میلوفیفروس اولیه; Post; essential thrombocythemia myelofibrosis; Post; polycythemia vera myelofibrosis; Primary myelofibrosis; Prognosis;
Keywords: میلوفیفروس اولیه; ASCT; allogeneic stem cell transplantation; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; GVHD; graft versus host disease; IPSS; International Prognostic Scoring System; MPN; myeloproliferative neoplasm; PMF; prima
Keywords: میلوفیفروس اولیه; JAK; Janus kinase; STAT; signal transducers and activators of transcription; EPOR; erythropoietin receptor; TPOR; thrombopoietin receptor; G-CSFR; granulocyte colony stimulating factor receptor; γc; common gamma chain; SCID; severe combined immunodeficie
Keywords: میلوفیفروس اولیه; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplant; BETi; bromodomain and extra terminal domain inhibitor; CR; complete remission; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; FAB; French-American-
Keywords: میلوفیفروس اولیه; Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Chronic myelogenous leukemia; Primary myelofibrosis;
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; RNA-seq; Apoptosis; Monozygotic twin; Childhood; Hematological disease;
Keywords: میلوفیفروس اولیه; Myeloproliferative disorders; Primary myelofibrosis; Janus kinase 2
Keywords: میلوفیفروس اولیه; Leukemic transformation; Mutations; Primary myelofibrosis; Prognosis; Survival
Keywords: میلوفیفروس اولیه; AMC; absolute monocyte count; AML; acute myeloid leukemia; BM; bone marrow; CMML; chronic myelomonocytic leukemia; CPSS; CMML-Specific Prognostic Scoring System; ESA; erythropoiesis-stimulating agent; GFM; Groupe Français des Myélodysplasies; GVHD; graf
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; Leukaemic transformation; Leukemic transformation risk; Anemia; Circulating blasts
Keywords: میلوفیفروس اولیه; Bone marrow fibrosis; Essential thrombocythemia; Polycythemia vera; Primary myelofibrosis; Ruxolitinib
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; Diagnostic discrepancy; JAKV617F mutation;
Keywords: میلوفیفروس اولیه; PMF; primary myelofibrosis; satTF; transferrin saturation; MCV; mean corpuscular volume; HB; hemoglobin; MDACC; MD Anderson Cancer Center; TTFT; time to first therapy; PFS; progression-free survival; LFS; leukemia-free survival; Primary myelofibrosis; Mic
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; Splenomegaly; Prognosis;
Keywords: میلوفیفروس اولیه; pierwotna mielofibroza; JAK2; ruksolitynib; Primary myelofibrosis; JAK2; Ruxolitinib;
Keywords: میلوفیفروس اولیه; primary myelofibrosis; essential throbocythemia; early/prefibrotic myelofibrosis; bone marrow biopsy
Keywords: میلوفیفروس اولیه; myeloproliferative neoplasm; leukemic transformation; leukemia etiology; polycythemia vera; essential thrombocythemia; primary myelofibrosis; antineoplastic agents; alkylators; hydroxyurea; radioactive phosphorous; X-ray treatment; JAK2 mutation; risk fac
Keywords: میلوفیفروس اولیه; Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Chronic myelogenous leukemia; Primary myelofibrosis;
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib
Keywords: میلوفیفروس اولیه; Langerhans cell histiocytosis; Primary myelofibrosis; JAK2; Ruxolitinib; Multilineage myeloid neoplasms; Laser microdissection;
Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms
Keywords: میلوفیفروس اولیه; Calreticulin; Somatic mutation; Allele burden; Myeloproliferative neoplasms; Pyrosequencing; BM; bone marrow; ddPCR; digital-droplet PCR; ET; essential thrombocythemia; MPN; myeloproliferative neoplasm; NGS; next-generation sequencing; PB; peripheral bloo
Actualités thérapeutiques dans les néoplasies myéloprolifératives non LMC
Keywords: میلوفیفروس اولیه; Myélofibrose primitive; polyglobulie de Vaquez; pronostic; thrombocytémie essentielle; traitement; Primary myelofibrosis; Polycythemia vera; prognosis; essential thrombocythemia; treatment;
Diagnostic anatomopathologique des néoplasies myéloprolifératives chroniques Ph-
Keywords: میلوفیفروس اولیه; Biopsie ostéo-médullaire; fibrose; maladie de Vaquez; myélofibrose primitive; pronostic; thrombocytémie essentielle; Bone marrow biopsy; fibrosis; prognosis; polycythemia vera; primary myelofibrosis; essential thrombocythemia;
JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms
Keywords: میلوفیفروس اولیه; JAK-STAT; Myeloproliferative neoplasm; JAK inhibitor; Ruxolitinib; Primary myelofibrosis;
CALR mutation profile in Irish patients with myeloproliferative neoplasms
Keywords: میلوفیفروس اولیه; CALR; Essential thrombocythemia; JAK2; Myeloproliferative neoplasm; Primary myelofibrosis;
Concomitant BCR-ABL1 positive chronic myelogenous leukemia emerging in a patient with MPL W515L associated primary myelofibrosis
Keywords: میلوفیفروس اولیه; Myeloproliferative neoplasms; Chronic myelogenous leukemia; Primary myelofibrosis; BCR-ABL1; MPL W515L
Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting
Keywords: میلوفیفروس اولیه; (JAK2); Janus kinase 2; (MPN); myeloproliferative neoplasms; (PV); polycythemia vera; (ET); essential thrombocythemia; (PMF); Primary myelofibrosis; (CALR); calreticulin; (HRM); high resolution melting; (CML); chronic myelogenous leukemia; (Hb); hemoglobi
SÃndromes mieloproliferativos
Keywords: میلوفیفروس اولیه; SÃndromes mieloproliferativos; Leucemia mieloide crónica; Policitemia vera; Trombocitemia esencial; Mielofibrosis primaria; Myeloproliferative diseases; Chronic myeloid leukemia; Polycythemia vera; Essential thrombocythemia; Primary myelofibrosis;
The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study
Keywords: میلوفیفروس اولیه; Angiogenesis; Essential thrombocytemia; Primary myelofibrosis; Thrombopoiesis; Wnt/β-catenin signaling pathway
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
Keywords: میلوفیفروس اولیه; Splanchnic vein thrombosis; Myeloproliferative neoplasm; Bone marrow morphology; Polycythemia vera; Primary myelofibrosis; Essential thrombocythemia
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; DNA methylation; PDGFB; FGF2; LINE-1;
Smoking as a contributing factor for development of polycythemia vera and related neoplasms
Keywords: میلوفیفروس اولیه; Smoking; Chronic myelomonocytic stimulation; Essential thrombocythemia; Polycythemia vera; Primary myelofibrosis; Myeloproliferative neoplasms MPNs; Thrombosis; Atherosclerosis; NF-κB; JAK-STAT-signaling; IL-8;
Biologie des syndromes myéloprolifératifs : classifications diagnostiques et nouveaux marqueurs moléculaires
Keywords: میلوفیفروس اولیه; Syndromes myéloproliferatifs; maladie de Vaquez; thrombocytémie essentielle; myélofibrose primitive; JAK2 V617F; mutation de CALR; pronostic; Myeloproliferative neoplasms; polycythemia vera; essential thrombocythemia; primary myelofibrosis; JAK2 V617F;
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
Keywords: میلوفیفروس اولیه; BM; bone marrow; CALR; calreticulin; CV; cardiovascular; Epo; erythropoietin; ET; essential thrombocythemia; JAK2; Janus kinase 2; MDS; myelodysplastic syndrome; MF; myelofibrosis; MPL; myeloproliferative leukemia virus oncogene; MPN; myeloproliferative
Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups
Keywords: میلوفیفروس اولیه; Myeloproliferative neoplasms; Polycythemia vera; Essential thrombocythemia; Primary myelofibrosis; Hematopoietic cell transplantation;
Increased angiogenesis in primary myelofibrosis: latent transforming growth factor-β as a possible angiogenic factor
Keywords: میلوفیفروس اولیه; Angiogenesis inducing agents; Primary myelofibrosis; Transforming growth factor beta; Antigens, CD34; Fibrosis
Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; Transplantation; Homologous; Janus Kinase 1; INCB018424
Evaluación sistemática de la biopsia de médula ósea en casos de sospecha de mielofibrosis primaria. Propuesta de informe diagnóstico estandarizado. Consenso de expertos de las SEAP/SEHH
Keywords: میلوفیفروس اولیه; Neoplasias mieloproliferativas; Mielofibrosis primaria; Biopsia de médula ósea; Informe histopatológico; Reticulina; Myeloproliferative neoplasms; Primary myelofibrosis; Bone marrow biopsy; Histopathological report; Reticulin;
JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms
Keywords: میلوفیفروس اولیه; Essential thrombocythemia; JAK2 mutation; MPNs; Polycythemia vera; Primary myelofibrosis
Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs
Keywords: میلوفیفروس اولیه; ATM; ataxia-telangiectasia mutated; Epo; erythropoietin; EpoR; erythropoietin receptor; ET; essential thrombocythemia; FA; Fanconi anemia; JAK2; Janus kinase 2; MPNs; myeloproliferative neoplasms; PMF; primary myelofibrosis; PV; polycythemia vera; RT-PCR;
MPL immunohistochemical expression as a novel marker for essential thrombocythemia and primary myelofibrosis differential diagnosis
Keywords: میلوفیفروس اولیه; Thrombopoietin receptor (MPL); Megakaryocytes; Primary myelofibrosis; Essential thrombocythemia; Immunohistochemistry; Fibrosis
WspóÅczesne leczenie pierwotnej mielofibrozy
Keywords: میلوفیفروس اولیه; pierwotna mielofibroza; przewlekÅe nowotwory mieloproliferacyjne; primary myelofibrosis; chronic myeloproliferative neoplasms;
High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis
Keywords: میلوفیفروس اولیه; Primary myelofibrosis; Whole blood gene expression profiling; Carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8; Inflammation; Cell adhesion; CD34+ cells; Angiogenesis
Actualités 2011 sur la physiopathologie des syndromes myéloprolifératifs classiques hors LMC (polyglobulie de Vaquez, thrombocytémie essentielle et myélofibrose primaire)
Keywords: میلوفیفروس اولیه; SMP : syndrome myéloprolifératif; PV : polyglobulie de Vaquez; TE : thrombocytémie essentielle; MPF : myélofibrose primaire; JAK2 : Janus activated kinase 2; MPL : myeloproliferative leukemia (récepteur de la thrombopoiétine); TET2 : Ten eleven tran
Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis
Keywords: میلوفیفروس اولیه; Myeloproliferative diseases; Primary myelofibrosis; Transforming growth factor beta; CCL64 cell line;
The myeloproliferative neoplasms including the eosinophilia-related myeloproliferations associated with tyrosine kinase mutations: changes and issues in classification and diagnosis criteria
Keywords: میلوفیفروس اولیه; Myeloproliferative neoplasms; Tyrosine kinase; Chronic myelogenous leukemia; Eosinophilia; Polycythemia vera; Essential thrombocythemia; Primary myelofibrosis; Mast cell disease;
The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis
Keywords: میلوفیفروس اولیه; Myelofibrosis; Myeloproliferative disorder; Primary myelofibrosis; Fatigue; Splenomegaly;